BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol. 2009;296:H585-H593. [PMID: 19136608 DOI: 10.1152/ajpheart.00463.2008] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Silverberg DS, Iaina A, Schwartz D, Wexler D. Intravenous Iron in Heart Failure: Beyond Targeting Anemia. Curr Heart Fail Rep 2011;8:14-21. [DOI: 10.1007/s11897-010-0034-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
2 Naito Y, Fujii A, Sawada H, Hirotani S, Iwasaku T, Eguchi A, Ohyanagi M, Tsujino T, Masuyama T. Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease. J Hypertens 2012;30:2192-201. [PMID: 22922699 DOI: 10.1097/HJH.0b013e3283581a64] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
3 Miura T, Sato T, Yano T, Takaguri A, Miki T, Tohse N, Nishizawa K. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms. Cardiovasc Drugs Ther 2022. [PMID: 35150385 DOI: 10.1007/s10557-022-07321-3] [Reference Citation Analysis]
4 de Araújo Azi LMT, Lopes FM, Garcia LV. Postoperative management of severe acute anemia in a Jehovah's Witness: Management of acute anemia in jehovah's witness. Transfusion 2014;54:1153-7. [DOI: 10.1111/trf.12424] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
5 Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J. Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. Transfusion 2016;56:2438-42. [PMID: 27385671 DOI: 10.1111/trf.13703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Silverberg DS, Wexler D, Iaina A, Schwartz D. Correction of iron deficiency in the cardiorenal syndrome. Int J Nephrol 2011;2011:365301. [PMID: 21603160 DOI: 10.4061/2011/365301] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
7 Bhagat N, Dawman L, Naganur S, Tiewsoh K, Kumar B, Pratyusha K, Sharawat IK, Gupta KL. Impact of anemia on the cardiovascular status in children with chronic kidney disease: A pilot study. Clinical Nutrition ESPEN 2022;47:283-7. [DOI: 10.1016/j.clnesp.2021.11.031] [Reference Citation Analysis]
8 Alcaide-Aldeano A, Garay A, Alcoberro L, Jiménez-Marrero S, Yun S, Tajes M, García-Romero E, Díez-López C, González-Costello J, Mateus-Porta G, Cainzos-Achirica M, Enjuanes C, Comín-Colet J, Moliner P. Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction. J Clin Med 2020;9:E1199. [PMID: 32331365 DOI: 10.3390/jcm9041199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Silverberg DS, Wexler D, Iaina A, Schwartz D. ANAEMIA MANAGEMENT IN CARDIO RENAL DISEASE: ANAEMIA MANAGEMENT IN CARDIO RENAL DISEASE. Journal of Renal Care 2010;36:86-96. [DOI: 10.1111/j.1755-6686.2010.00164.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
10 Silverberg DS. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome. Heart Fail Rev 2011;16:609-14. [DOI: 10.1007/s10741-010-9194-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
11 Xu Y, Hu T, Ding H, Chen R. Effects of anemia on the survival of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Expert Rev Respir Med 2020;14:1267-77. [PMID: 32869670 DOI: 10.1080/17476348.2020.1816468] [Reference Citation Analysis]
12 Alexandrakis MG, Tsirakis G. Anemia in heart failure patients. ISRN Hematol 2012;2012:246915. [PMID: 22536520 DOI: 10.5402/2012/246915] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
13 Chairat K, Rattanavipanon W, Tanyasaensook K, Chindavijak B, Chulavatnatol S, Nathisuwan S. Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand. Int J Cardiol Heart Vasc 2020;30:100597. [PMID: 32775603 DOI: 10.1016/j.ijcha.2020.100597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Senthong V, Hudec T, Neale S, Wu Y, Hazen SL, Tang WH. Relation of Red Cell Distribution Width to Left Ventricular End-Diastolic Pressure and Mortality in Patients With and Without Heart Failure. Am J Cardiol 2017;119:1421-7. [PMID: 28285713 DOI: 10.1016/j.amjcard.2017.01.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Dimitrijevic ZM, Salinger Martinovic SS, Nikolic VN, Cvetkovic TP. Protein Carbonyl Content Is a Predictive Biomarker of Eccentric Left Ventricular Hypertrophy in Hemodialysis Patients. Diagnostics (Basel) 2019;9:E202. [PMID: 31775390 DOI: 10.3390/diagnostics9040202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Mistry N, Mazer CD, Sled JG, Lazarus AH, Cahill LS, Solish M, Zhou YQ, Romanova N, Hare AGM, Doctor A, Fisher JA, Brunt KR, Simpson JA, Hare GMT. Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain. Am J Physiol Regul Integr Comp Physiol 2018;314:R611-22. [PMID: 29351418 DOI: 10.1152/ajpregu.00182.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
17 Subramanian M, Prabhu MA, Saravanan S, Thachathodiyl R. Bio-width index: a novel biomarker for prognostication of long term outcomes in patients with anaemia and heart failure. Acta Cardiol 2018;73:403-9. [PMID: 29214898 DOI: 10.1080/00015385.2017.1408890] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 El Hasnaoui-saadani R, Marchant D, Pichon A, Escoubet B, Pezet M, Hilfiker-kleiner D, Hoch M, Pham I, Quidu P, Voituron N, Journé C, Richalet J, Favret F. Epo deficiency alters cardiac adaptation to chronic hypoxia. Respiratory Physiology & Neurobiology 2013;186:146-54. [DOI: 10.1016/j.resp.2013.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
19 Chamieh JS, Tamim HM, Masrouha KZ, Saghieh SS, Al-taki MM. The Association of Anemia and Its Severity with Cardiac Outcomes and Mortality After Total Knee Arthroplasty in Noncardiac Patients. The Journal of Arthroplasty 2016;31:766-70. [DOI: 10.1016/j.arth.2015.10.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
20 Gao E, Koch WJ. Is erythropoietin behind maladaptive anemic heart failure? American Journal of Physiology-Heart and Circulatory Physiology 2009;296:H559-60. [DOI: 10.1152/ajpheart.00045.2009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Beale AL, Warren JL, Roberts N, Meyer P, Townsend NP, Kaye D. Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Open Heart 2019;6:e001012. [PMID: 31168385 DOI: 10.1136/openhrt-2019-001012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
22 Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol 2013; 2(2): 38-43 [PMID: 24175264 DOI: 10.5527/wjn.v2.i2.38] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
23 Leszek P, Sochanowicz B, Brzóska K, Kraj L, Kuśmierczyk M, Śmigielski W, Rywik TM, Sobieszczańska-Małek M, Rozentryt P, Kruszewski M. Accurate Noninvasive Assessment of Myocardial Iron Load in Advanced Heart Failure Patients. Dis Markers 2020;2020:8885189. [PMID: 33224316 DOI: 10.1155/2020/8885189] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Jankowska EA, Ponikowski P. Molecular Changes in Myocardium in the Course of Anemia or Iron Deficiency. Heart Failure Clinics 2010;6:295-304. [DOI: 10.1016/j.hfc.2010.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
25 Kim SJ, Oh HJ, Yoo DE, Shin DH, Lee MJ, Kim HR, Park JT, Han SH, Yoo TH, Choi KH, Kang SW. Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients. PLoS One 2012;7:e35534. [PMID: 22530043 DOI: 10.1371/journal.pone.0035534] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
26 Alfieri C, Vettoretti S, Ruzhytska O, Gandolfo MT, Cresseri D, Campise M, Caldiroli L, Favi E, Binda V, Messa P. Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study. Sci Rep 2020;10:19160. [PMID: 33154468 DOI: 10.1038/s41598-020-76261-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Forbes G, Feary D, Savage C, Nath L, Church S, Lording P. Acute myeloid leukaemia (M6B: pure acute erythroid leukaemia) in a Thoroughbred foal: EQUINE. Australian Veterinary Journal 2011;89:269-72. [DOI: 10.1111/j.1751-0813.2011.00790.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
28 Eguchi A, Naito Y, Iwasaku T, Okuhara Y, Morisawa D, Sawada H, Nishimura K, Oboshi M, Fujii K, Mano T, Masuyama T, Hirotani S. Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice. Heart Vessels 2016;31:222-9. [PMID: 25573257 DOI: 10.1007/s00380-014-0621-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
29 Toblli JE, Di Gennaro F, Rivas C. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. Heart Lung Circ 2015;24:686-95. [PMID: 25666998 DOI: 10.1016/j.hlc.2014.12.161] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
30 Koo HM, Kim CH, Doh FM, Lee MJ, Kim EJ, Han JH, Han JS, Oh HJ, Park JT, Han SH, Yoo TH, Kang SW. The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis. PLoS One 2014;9:e87231. [PMID: 24505281 DOI: 10.1371/journal.pone.0087231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
31 Qian C, Wei B, Ding J, Wu H, Wang Y. The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis. Can J Cardiol 2016;32:151-9. [PMID: 26454467 DOI: 10.1016/j.cjca.2015.06.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
32 Martens P, Verbrugge F, Nijst P, Dupont M, Tang WW, Mullens W. Impact of Iron Deficiency on Response to and Remodeling After Cardiac Resynchronization Therapy. The American Journal of Cardiology 2017;119:65-70. [DOI: 10.1016/j.amjcard.2016.09.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
33 Hammoudi N, Lionnet F, Redheuil A, Montalescot G. Cardiovascular manifestations of sickle cell disease. European Heart Journal 2020;41:1365-73. [DOI: 10.1093/eurheartj/ehz217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
34 Paterek A, Mackiewicz U, Mączewski M. Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities. J Cell Physiol 2019;234:21613-29. [DOI: 10.1002/jcp.28820] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
35 Rao NN, Dundon BK, Worthley MI, Faull RJ. The Impact of Arteriovenous Fistulae for Hemodialysis on the Cardiovascular System. Semin Dial 2016;29:214-21. [DOI: 10.1111/sdi.12459] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
36 Toblli JE, Cao G, Rivas C, Giani JF, Dominici FP. Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation. International Journal of Cardiology 2016;212:84-91. [DOI: 10.1016/j.ijcard.2016.03.039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
37 Naito Y, Sawada H, Oboshi M, Fujii A, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Morisawa D, Ohyanagi M, Tsujino T, Masuyama T. Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats. PLoS One 2013;8:e75906. [PMID: 24116080 DOI: 10.1371/journal.pone.0075906] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
38 Stoyanova E, Cloutier G, Felfly H, Lemsaddek W, Ah-Son N, Trudel M. Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis. PLoS One 2012;7:e52128. [PMID: 23284899 DOI: 10.1371/journal.pone.0052128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
39 Westphal JG, Bekfani T, Schulze PC. What’s new in heart failure therapy 2018?†. Interactive CardioVascular and Thoracic Surgery 2018;27:921-30. [DOI: 10.1093/icvts/ivy282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Hasin T, Sorkin A, Markiewicz W, Hammerman H, Aronson D. Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction. Am J Cardiol 2009;104:486-91. [PMID: 19660599 DOI: 10.1016/j.amjcard.2009.03.066] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
41 Naito Y, Hosokawa M, Hao H, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Hirota S, Ohyanagi M. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats. Biochem Biophys Res Commun. 2013;436:145-151. [PMID: 23707944 DOI: 10.1016/j.bbrc.2013.05.059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
42 Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, Rostami F, Reboll MR, Heineke J, Flögel U, Groos S, Renner A, Toischer K, Zimmermann F, Engeli S, Jordan J, Bauersachs J, Hentze MW, Wollert KC, Kempf T. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J 2017;38:362-72. [PMID: 27545647 DOI: 10.1093/eurheartj/ehw333] [Cited by in Crossref: 28] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
43 Kobak KA, Radwańska M, Dzięgała M, Kasztura M, Josiak K, Banasiak W, Ponikowski P, Jankowska EA. Structural and functional abnormalities in iron-depleted heart. Heart Fail Rev 2019;24:269-77. [PMID: 30284070 DOI: 10.1007/s10741-018-9738-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
44 Silverberg D, Iaina A, Wexler D, Schwartz D. Iron Repletion in Heart Failure Patients. Hypertension 2011;57:381-2. [DOI: 10.1161/hypertensionaha.110.166868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Li Y, Zhang H, Liao W, Song Y, Ma X, Chen C, Lu Z, Li Z, Zhang Y. Transactivated EGFR mediates α 1 -AR-induced STAT3 activation and cardiac hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology 2011;301:H1941-51. [DOI: 10.1152/ajpheart.00338.2011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
46 Maeder MT, Khammy O, dos Remedios C, Kaye DM. Myocardial and Systemic Iron Depletion in Heart Failure. Journal of the American College of Cardiology 2011;58:474-80. [DOI: 10.1016/j.jacc.2011.01.059] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 8.4] [Reference Citation Analysis]
47 Parisi P, Villa MP, Donfrancesco R, Miano S, Paolino MC, Cortese S. Could treatment of iron deficiency both improve ADHD and reduce cardiovascular risk during treatment with ADHD drugs? Medical Hypotheses 2012;79:246-9. [DOI: 10.1016/j.mehy.2012.04.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
48 Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol. 2009;4 Suppl 1:S79-S91. [PMID: 19996010 DOI: 10.2215/cjn.04860709] [Cited by in Crossref: 208] [Cited by in F6Publishing: 87] [Article Influence: 17.3] [Reference Citation Analysis]
49 Padda J, Khalid K, Hitawala G, Batra N, Pokhriyal S, Mohan A, Cooper AC, Jean-Charles G. Acute Anemia and Myocardial Infarction. Cureus 2021;13:e17096. [PMID: 34527482 DOI: 10.7759/cureus.17096] [Reference Citation Analysis]
50 Peters BS, Dornaika R, Hosten N, Hadlich S, Mullins JJ, Peters J, Rettig R. Regression of cardiac hypertrophy in cyp1a1ren-2 transgenic rats. J Magn Reson Imaging 2012;36:373-8. [PMID: 22517449 DOI: 10.1002/jmri.23661] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Song D, Li Y, Cao J, Han Z, Gao L, Xu Z, Yin Z, Wang G, Fan Y, Wang C. Effect of iron deficiency on c-kit⁺ cardiac stem cells in vitro. PLoS One 2013;8:e65721. [PMID: 23762416 DOI: 10.1371/journal.pone.0065721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
52 Hayashi T, Kimura T, Yasuda K, Obi Y, Sasaki K, Iio K, Miyasato K, Kamimura T, Kitamura H, Tsubakihara Y, Rakugi H, Isaka Y. Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents. Clin Exp Nephrol 2013;17:294-303. [PMID: 23100176 DOI: 10.1007/s10157-012-0705-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Amaral N, Okonko DO. Metabolic abnormalities of the heart in type II diabetes. Diabetes and Vascular Disease Research 2015;12:239-48. [DOI: 10.1177/1479164115580936] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
54 Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013;34:816-29. [PMID: 23100285 DOI: 10.1093/eurheartj/ehs224] [Cited by in Crossref: 200] [Cited by in F6Publishing: 183] [Article Influence: 20.0] [Reference Citation Analysis]
55 Mandour AS, Elsayed RF, Ali AO, Mahmoud AE, Samir H, Dessouki AA, Matsuura K, Watanabe I, Sasaki K, Al-Rejaie S, Yoshida T, Shimada K, Tanaka R, Watanabe G. The utility of electrocardiography and echocardiography in copper deficiency-induced cardiac damage in goats. Environ Sci Pollut Res Int 2021;28:7815-27. [PMID: 33037959 DOI: 10.1007/s11356-020-11014-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Wong CC, Ng AC, Kritharides L, Sindone AP. Iron Deficiency in Heart Failure: Looking Beyond Anaemia. Heart, Lung and Circulation 2016;25:209-16. [DOI: 10.1016/j.hlc.2015.06.827] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
57 Rao NN, Coates PT. Cardiovascular Disease After Kidney Transplant. Semin Nephrol 2018;38:291-7. [PMID: 29753404 DOI: 10.1016/j.semnephrol.2018.02.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
58 Moliner P, Enjuanes C, Tajes M, Cainzos-Achirica M, Lupón J, Garay A, Jimenez-Marrero S, Yun S, Farré N, Cladellas M, Díez C, Gonzalez-Costello J, Comin-Colet J. Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity? J Am Heart Assoc 2019;8:e010887. [PMID: 30760082 DOI: 10.1161/JAHA.118.010887] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
59 Choi AW, Fong N, Li VW, Ho T, Chan EY, Ma AL, Cheung Y. Left ventricular stiffness in paediatric patients with end-stage kidney disease. Pediatr Nephrol 2020;35:1051-60. [DOI: 10.1007/s00467-020-04484-9] [Reference Citation Analysis]
60 Liu J, Ai YX, Hanlon A, Shi Z, Dickerman B, Compher C. Micronutrients deficiency and associated sociodemographic factors in Chinese children. World J Pediatr 2011;7:217-23. [PMID: 21822989 DOI: 10.1007/s12519-011-0317-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
61 McMurray J, Ponikowski P. Heart failure not enough pump iron? J Am Coll Cardiol 2011;58:481-2. [PMID: 21777744 DOI: 10.1016/j.jacc.2011.02.066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
62 Moliner P, Jankowska EA, van Veldhuisen DJ, Farre N, Rozentryt P, Enjuanes C, Polonski L, Meroño O, Voors AA, Ponikowski P, Van der Meer P, Comin-colet J. Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure. International Journal of Cardiology 2017;243:360-6. [DOI: 10.1016/j.ijcard.2017.04.110] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
63 Hayashi T, Joki N, Tanaka Y, Hase H. Anaemia and early phase cardiovascular events on haemodialysis. Nephrology (Carlton) 2015;20 Suppl 4:1-6. [PMID: 26456311 DOI: 10.1111/nep.12642] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
64 Silverberg DS, Schwartz D. The Role of Iron, Omega-3 Fatty Acids, and Vitamins in Heart Failure. Curr Treat Options Cardio Med 2012;14:328-41. [DOI: 10.1007/s11936-012-0188-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
65 Hammoudi N, Arangalage D, Djebbar M, Stojanovic KS, Charbonnier M, Isnard R, Girot R, Michel PL, Lionnet F. Subclinical left ventricular systolic impairment in steady state young adult patients with sickle-cell anemia. Int J Cardiovasc Imaging 2014;30:1297-304. [PMID: 24952634 DOI: 10.1007/s10554-014-0473-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
66 Naito Y, Hirotani S, Sawada H, Akahori H, Tsujino T, Masuyama T. Dietary Iron Restriction Prevents Hypertensive Cardiovascular Remodeling in Dahl Salt-Sensitive Rats. Hypertension 2011;57:497-504. [DOI: 10.1161/hypertensionaha.110.159681] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
67 Beale A, Carballo D, Stirnemann J, Garin N, Agoritsas T, Serratrice J, Kaye D, Meyer P, Carballo S. Iron Deficiency in Acute Decompensated Heart Failure. J Clin Med 2019;8:E1569. [PMID: 31581494 DOI: 10.3390/jcm8101569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
68 Saini N, Helfrich KK, Kwan STC, Huebner SM, Abazi J, Flentke GR, Blohowiak SE, Kling PJ, Smith SM. Alcohol's Dysregulation of Maternal-Fetal IL-6 and p-STAT3 Is a Function of Maternal Iron Status. Alcohol Clin Exp Res 2019;43:2332-43. [PMID: 31524964 DOI: 10.1111/acer.14200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Ali EMT, El-Sayed SM, Elbastawisy YM. Ultrastructural aberrations, histological disruption and upregulation of the VEGF, CD34 and ASMA immunoexpression in the myocardium of anemic albino rats. Acta Histochem 2021;123:151731. [PMID: 34052675 DOI: 10.1016/j.acthis.2021.151731] [Reference Citation Analysis]
70 Rastmanesh R. Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration. Int J Gen Med 2011;4:647-56. [PMID: 21941450 DOI: 10.2147/IJGM.S23206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Weber CS, Beck-da-Silva L, Goldraich LA, Biolo A, Clausell N. Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients. Acta Haematol. 2013;129:55-61. [PMID: 23147477 DOI: 10.1159/000342110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
72 Gangopadhyay R, Karoshi M, Keith L. Anemia and pregnancy: a link to maternal chronic diseases. Int J Gynaecol Obstet 2011;115 Suppl 1:S11-5. [PMID: 22099433 DOI: 10.1016/S0020-7292(11)60005-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
73 Naito Y, Tsujino T, Fujimori Y, Sawada H, Akahori H, Hirotani S, Ohyanagi M, Masuyama T. Impaired expression of duodenal iron transporters in Dahl salt-sensitive heart failure rats. J Hypertens 2011;29:741-8. [PMID: 21191310 DOI: 10.1097/HJH.0b013e3283434784] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
74 Naito Y, Masuyama T, Ishihara M. Iron and cardiovascular diseases. J Cardiol 2021;77:160-5. [PMID: 32739111 DOI: 10.1016/j.jjcc.2020.07.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Núñez J, Domínguez E, Ramón JM, Núñez E, Sanchis J, Santas E, Heredia R, González J, Miñana G, López L, Chorro FJ, Palau P. Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction. Int J Cardiol 2016;207:365-7. [PMID: 26820369 DOI: 10.1016/j.ijcard.2016.01.187] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
76 Charytan D. Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease. Curr Opin Nephrol Hypertens 2014;23:578-85. [PMID: 25295959 DOI: 10.1097/MNH.0000000000000067] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
77 Dinatolo E, Dasseni N, Metra M, Lombardi C, von Haehling S. Iron deficiency in heart failure. J Cardiovasc Med (Hagerstown) 2018;19:706-16. [PMID: 30222663 DOI: 10.2459/JCM.0000000000000686] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kawano F, Oke Y, Nomura S, Fujita R, Ohira T, Nakai N, Ohira Y. Responses of HSC70 expression in diencephalon to iron deficiency anemia in rats. J Physiol Sci 2011;61:445-56. [PMID: 21811788 DOI: 10.1007/s12576-011-0164-9] [Reference Citation Analysis]
79 Zhou Q, Shen J, Liu Y, Luo R, Tan B, Li G. Assessment of left ventricular systolic function in patients with iron deficiency anemia by three-dimensional speckle-tracking echocardiography. Anatol J Cardiol 2017;18:194-9. [PMID: 28639946 DOI: 10.14744/AnatolJCardiol.2017.7694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
80 Gevaert AB, Mueller S, Winzer EB, Duvinage A, Van de Heyning CM, Pieske-kraigher E, Beckers PJ, Edelmann F, Wisløff U, Pieske B, Adams V, Halle M, Van Craenenbroeck EM; for the OptimEx-Clin Study Group. Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study. Front Physiol 2022;12:757268. [DOI: 10.3389/fphys.2021.757268] [Reference Citation Analysis]
81 Han YM, Yoon H, Shin CM, Koh SJ, Im JP, Kim BG, Kim JS, Jung HC. Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. Gut Liver 2016;10:562-8. [PMID: 27021505 DOI: 10.5009/gnl15373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Naito Y, Sawada H, Oboshi M, Iwasaku T, Okuhara Y, Morisawa D, Eguchi A, Hirotani S, Mano T, Tsujino T, Masuyama T. Cardiac remodeling in response to chronic iron deficiency: role of the erythropoietin receptor. Journal of Hypertension 2015;33:1267-75. [DOI: 10.1097/hjh.0000000000000547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]